Cargando…

Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model

BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) is a common skin cancer, affecting more than 2 million people worldwide yearly and metastasising in 2–5% of patients. However, current clinical staging systems do not provide estimates of absolute metastatic risk, hence missing the opportunity for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rentroia-Pacheco, Barbara, Tokez, Selin, Bramer, Edo M., Venables, Zoe C., van de Werken, Harmen J.G., Bellomo, Domenico, van Klaveren, David, Mooyaart, Antien L., Hollestein, Loes M., Wakkee, Marlies
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468358/ https://www.ncbi.nlm.nih.gov/pubmed/37662519 http://dx.doi.org/10.1016/j.eclinm.2023.102150

Ejemplares similares

Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data
por: Venables, Zoe Claire, et al.
Publicado: (2022)

Primary Melanoma Characteristics of Metastatic Disease: A Nationwide Cancer Registry Study
por: Zhou, Catherine, et al.
Publicado: (2021)

Genetic Concordance in Primary Cutaneous Melanoma and Matched Metastasis: A Systematic Review and Meta-Analysis
por: Kerkour, Thamila, et al.
Publicado: (2023)

Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I–II Melanoma Patients at Risk of Disease Relapse
por: Mulder, Evalyn E. A. P., et al.
Publicado: (2022)

Validation of a Market-Approved Artificial Intelligence Mobile Health App for Skin Cancer Screening: A Prospective Multicenter Diagnostic Accuracy Study
por: Sangers, Tobias, et al.
Publicado: (2022)

Predicting keratinocyte carcinoma in patients with actinic keratosis: development and internal validation of a multivariable risk‐prediction model
por: Tokez, S., et al.
Publicado: (2020)

Increasing Costs of Skin Cancer due to Increasing Incidence and Introduction of Pharmaceuticals, 2007–2017
por: NOELS, Eline, et al.
Publicado: (2020)

Limited impact of COVID‐19‐related diagnostic delay on cutaneous melanoma and squamous cell carcinoma tumour characteristics: a nationwide pathology registry analysis
por: Sangers, Tobias E., et al.
Publicado: (2022)

An artificial intelligence based app for skin cancer detection evaluated in a population based setting
por: Smak Gregoor, Anna M., et al.
Publicado: (2023)

Skin cancer special issue in Skin Health and Disease
por: Yélamos, Oriol, et al.
Publicado: (2023)

What do patients and dermatologists prefer regarding low-risk basal cell carcinoma follow-up care? A discrete choice experiment
por: van Egmond, Sven, et al.
Publicado: (2021)

What are the most important factors in basal cell carcinoma follow‐up care? The perspective of patients
por: van Egmond, S., et al.
Publicado: (2020)

Outcome after treatment for sebaceous carcinoma: A multicenter study
por: In 't Veld, Eva Huis, et al.
Publicado: (2022)

Clinical findings are not helpful in detecting lentigo maligna melanoma in patients with biopsy‐proven lentigo maligna
por: Zoutendijk, J., et al.
Publicado: (2022)

Tread carefully when considering vulvar melanoma in a child or adolescent
por: Morrel, Beth, et al.
Publicado: (2023)

Polygenic risk scores for melanoma: a stepwise process towards clinical implementation
por: Wakkee, Marlies
Publicado: (2022)

Predicting personalised absolute treatment effects in individual participant data meta‐analysis: An introduction to splines
por: Belias, Michail, et al.
Publicado: (2022)

Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma
por: Huis in ’t Veld, Eva A., et al.
Publicado: (2023)

A Scoping Review and Population Study Regarding Prevalence and Histopathology of Juvenile Vulvar Melanocytic Lesions. A Recommendation
por: Morrel, Beth, et al.
Publicado: (2022)

Trichoblastic carcinosarcoma with panfollicular differentiation (panfollicular carcinosarcoma) and CTNNB1 (beta‐catenin) mutation
por: Giang, Jenny, et al.
Publicado: (2020)

Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study
por: Weesie, F., et al.
Publicado: (2019)

ProteoDisco: a flexible R approach to generate customized protein databases for extended search space of novel and variant proteins in proteogenomic studies
por: van de Geer, Wesley S, et al.
Publicado: (2021)

FASTAFS: file system virtualisation of random access compressed FASTA files
por: Hoogstrate, Youri, et al.
Publicado: (2021)

Katdetectr: an R/bioconductor package utilizing unsupervised changepoint analysis for robust kataegis detection
por: Hazelaar, Daan M, et al.
Publicado: (2023)

The healthy user and healthy adherer bias: a nested case-control study among statin users in the Rotterdam Study
por: Hollestein, Loes, et al.
Publicado: (2015)

Personalised Medicine with IL-23 Blockers: Myth or Reality?
por: Gottlieb, Zoë S, et al.
Publicado: (2021)

PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells
por: Agrawal Singh, Shuchi, et al.
Publicado: (2019)

Personalised diet
Publicado: (2011)

Personalised Ecology
por: Gaston, Kevin J., et al.
Publicado: (2018)

Targeted Chromatin Capture (T2C): a novel high resolution high throughput method to detect genomic interactions and regulatory elements
por: Kolovos, Petros, et al.
Publicado: (2014)

The funhouse mirror: the I in personalised healthcare
por: Vegter, Mira W., et al.
Publicado: (2021)

Treatment of Pain in Cancer: Towards Personalised Medicine
por: van den Beuken-van Everdingen, Marieke H. J., et al.
Publicado: (2018)

Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis
por: Noels, E. C., et al.
Publicado: (2019)

Perspective: Towards Personalised Metabolic Coaching in Cancer
por: Van Soom *, T, et al.
Publicado: (2018)

Efficacy, cost-minimization, and budget impact of a personalized discharge letter for basal cell carcinoma patients to reduce low-value follow-up care
por: van Egmond, Sven, et al.
Publicado: (2022)

JOCR: Personalised Journal, Personalised Network and Clinical Decision Making (CDM)
por: Shyam, Ashok
Publicado: (2012)

Personalised organs-on-chips: functional testing for precision medicine
por: van den Berg, Albert, et al.
Publicado: (2019)

Personalised nutrition and health
por: Ordovas, Jose M, et al.
Publicado: (2018)

Personalised Medicine in Europe
por: Andriukaitis, Vytenis
Publicado: (2017)

Association Between CNDP1 Genotype and Diabetic Nephropathy Is Sex Specific
por: Mooyaart, Antien L., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_jf837m01pknfg4lcrroet55cjv